It is suggested that the abaI gene boosts capsule production and pathogenicity of A. baumannii, providing new insights for clinical management of drug-resistant A. baumannii diseases and a foundation for new antimicrobial drugs.
Abstract
Introduction Acinetobacter baumannii (A. baumannii) is a Gram-negative coccobacillus that can cause a variety of infectious diseases. The Quorum Sensing (QS) system is a widespread mechanism regulating group behavior in bacteria, playing a crucial role in the virulence regulation of several Gram-negative pathogenic bacteria. The aim of this study was to investigate the effects of the A. baumannii quorum sensing system on capsule production and pathogenicity. Methods In this work, a clinical carbapenem-resistant A. baumannii with mucoid colonies (CRAB110) was used to construct an abaI knockout strain (CRAB110ΔabaI) using CRISPR/Cas9 system. Afterwards, changes in capsule production, bacterial virulence, and host immune responses were evaluated by assessing bacterial phenotypes, physiology, gene expression, and effects on the host. Results The results showed that CRAB110ΔabaI significantly affected capsule production, virulence, and immunity compared with CRAB110. Mice infected with CRAB110ΔabaI exhibited a reduction in inflammation compared to those infected with CRAB110. A comparison of the transcriptomes of CRAB110 and CRAB110ΔabaI identified differentially expressed genes related to polysaccharide synthesis (wza, wzb, wzc), galactose metabolism (GalM), ABC transport, and amino acid metabolism. Mouse lung transcriptomic and cellular Western blot data indicated that quorum sensing (QS) exerts its pro-inflammatory effect through Acinetobacter baumannii by influencing the IL-17 and NF-κB pathways. Conclusion This study suggests that the abaI gene boosts capsule production and pathogenicity of A. baumannii, providing new insights for clinical management of drug-resistant A. baumannii diseases and a foundation for new antimicrobial drugs.
Background:
Zoonotic diseases are illnesses that humans can contract from animals and vice versa. Pseudomonas aeruginosa is an opportunistic organism that makes treating infections challenging, particularly in individuals with underlying medical conditions and those with impaired immune systems. The increasing number o...
Abdul-Nafea Hassan, Ibtisam Q. Abdulkareem· Open Veterinary Journal· 0 citations
The findings expand current knowledge of the chemical profiles of signaling molecules produced by high-biofilm-forming A. baumannii isolates and provide a basis for future studies investigating their potential biological significance.
Bhavya Jayanth Nirmala, A. Naik, Rajitha Golla Venkateshulu et al.· Current Microbiology· 0 citations
Edwardsiella piscicida is a devastating bacterial pathogen in aquaculture, and in-depth elucidation of its pathogenic mechanisms is essential for establishing effective control strategies; the identification of novel regulatory factors can deepen our understanding of bacterial pathogenesis. Our previous work identified...
Xian-Cheng Jiang, Han-Jie Gu, Yan Wang et al.· Frontiers in Cellular and In...· 0 citations
Backgroud Carbapenem-resistant Acinetobacter baumannii (CRAB) has become a predominant nosocomial pathogen worldwide, with biofilm formation and quorum sensing (QS) primarily responsible for its high antimicrobial tolerance and clinical refractory infections. Targeting bacterial virulence rather than conventional bacte...
Bin Liu, Cai-Hua Li, Yi-Zhen Zhu et al.· Frontiers in Microbiology· 0 citations
Critical insights into the development of multidrug resistance in nosocomial pathogens are provided and could enlighten novel drug designs and strategies to combat infections in both clinical and environmental settings.